At a Glance
| PARGY-LAD | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 275–500 µg | 100–225 µg |
| Total Duration | 0.5–0.8 hrs | 3.3–7 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 72 documented |
PARGY-LAD, a Psychedelic, and 1cP-AL-LAD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 55 documented effects in common, with 17 effects unique to PARGY-LAD and 17 unique to 1cP-AL-LAD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| PARGY-LAD | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 275–500 µg | 100–225 µg |
| Total Duration | 0.5–0.8 hrs | 3.3–7 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 72 documented |
| Level | PARGY-LAD | 1cP-AL-LAD |
|---|---|---|
| Threshold | 50 µg | 20 µg |
| Light | 125–275 µg | 50–100 µg |
| Common | 275–500 µg | 100–225 µg |
| Strong | 500–700 µg | 225–350 µg |
| Heavy | 700 µg | 350 µg |
PARGY-LAD
1cP-AL-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.